Mage Biologics
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of MB-001 in Moderately to Severely Active Ulcerative Colitis (NCT07374471) | Mage Biologics | 2026-04-01 |
| A Phase 1 Study to Evaluate the Safety of an Oral Biologic in Healthy Participants (NCT06363383) | Mage Biologics | 2024-05-09 |
Track Mage Biologics automatically
Every clearance here is in the API, with alerts when new ones post.